Madhav Prasad Yadav - Concepedia

Author

Madhav Prasad Yadav

All India Institute of Medical Sciences

Also Known As

Madhav P Yadav, Madhav P. Yadav, Madhav Prasad Yadav, Madhav Yadav

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

All India Institute of Medical Sciences Johannes Gutenberg University Mainz DR. B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical Sciences Raipur All India Institute of Medical Sciences Bhopal

About

Madhav Prasad Yadav is an author at All India Institute of Medical Sciences specializing in medicine, oncology, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Health Sciences	7	7	370
3	Engineering	3	3	172
4	Natural Sciences	1	1	15
5	Biomolecular Engineering	1	1	57

Madhav Prasad Yadav

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal, European Journal of Nuclear Medicine and Molecular Imaging 177Lu-dotatate PrrtFirst Clinical ExperienceMedicinePharmacologyNeuroendocrine Disorder	2019	201
Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study Mike Sathekge, Ismaheel O. Lawal, Chandrasekhar Bal, The Lancet Oncology Retrospective StudyUrologyRadiation MedicineMedicineRadiopharmaceutical Therapy	2024	157
177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment Madhav Prasad Yadav, Sanjana Ballal, Madhavi Tripathi, European Journal of Nuclear Medicine and Molecular Imaging Life AssessmentUrologyOncologyGenitourinary CancerCancer Management	2016	146
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyNeuro-oncologyOncologic ImagingRadiation TherapyMedicine	2020	144
Efficacy and safety of <sup>225</sup>Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Theranostics	2020	142
A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy Sanjana Ballal, Madhav Prasad Yadav, Vasko Kramer, European Journal of Nuclear Medicine and Molecular Imaging Adaptive RadiotherapyEngineeringMedicineRadionuclide TherapyTheranostic Approach	2020	121
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2 Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Pharmaceuticals	2021	118
Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal, Clinical Nuclear Medicine	2019	108
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon, Thyroid	2021	104
Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, European Journal of Nuclear Medicine and Molecular Imaging Neuro-oncologyMetastatic ParagangliomasSurgical OncologyHealth SciencesMedicine	2021	81

Page 1